Exascale Labs–BCAR (NASDAQ: BCAR) merger vote set for Jul 29

Filing Impact

(High)

Filing Sentiment

(Neutral)

Form Type

8-K

Rhea-AI Filing Summary

D. Boral ARC Acquisition I Corp. (BCAR) has scheduled an Extraordinary General Meeting of shareholders for July 29, 2026 at 10:00 a.m. Eastern Time to vote on its previously announced business combination with Exascale Labs Inc.

Shareholders of record as of July 6, 2026 may attend and vote, either in person at Loeb & Loeb LLP in New York or virtually via proxydocs.com/BCAR. If approved and closing conditions are satisfied or waived, the combined company is expected to operate as Exascale Labs Holdings Inc. with its shares trading on Nasdaq under the ticker “XLAB.”

Insights

BCAR locks in shareholder vote date for Exascale merger.

BCAR, a special purpose acquisition company, has set July 29, 2026 for shareholders to vote on its business combination with Exascale Labs, an AI compute infrastructure provider. This formalizes the approval timeline after prior announcement of the deal.

The parties state that, subject to shareholder approval and closing conditions, the combined company will operate as Exascale Labs Holdings Inc. and list on Nasdaq under ticker “XLAB”. The filing reiterates standard forward-looking statement and risk disclosures, emphasizing execution, demand, supply, and regulatory uncertainties.

The next concrete milestone is the Extraordinary General Meeting on July 29, 2026, where voting outcomes will determine whether the transaction proceeds toward closing or requires further steps or amendments.

8-K Event Classification

2 items: 8.01, 9.01

2 items

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

Key Figures

Shareholder meeting date: July 29, 2026, 10:00 a.m. ET Record date: July 6, 2026 Warrant exercise price: $11.50 per share +2 more

5 metrics

Shareholder meeting date July 29, 2026, 10:00 a.m. ET Extraordinary General Meeting to approve Business Combination

Record date July 6, 2026 Shareholders of record eligible to vote at Meeting

Warrant exercise price $11.50 per share BCAR warrants exercisable for one Class A ordinary share

Post-merger ticker XLAB Expected Nasdaq ticker for Exascale Labs Holdings Inc.

Form S-4 file number 333-297214 Registration Statement including proxy statement/prospectus

Key Terms

Business Combination, special purpose acquisition company, Registration Statement on Form S-4, Proxy Statement, +2 more

6 terms

Business Combination financial

"the previously announced proposed business combination between Exascale and BCAR (the “Business Combination”)"

A business combination happens when two or more companies join together to operate as one, like two friends merging their teams into a single group. This is important because it can change how companies grow, compete, and make money, often making them bigger and more powerful in the market.

special purpose acquisition company financial

"BCAR, a special purpose acquisition company, today announced that the Extraordinary General Meeting"

A special purpose acquisition company (SPAC) is a company formed with the sole purpose of raising money through a public offering to buy or merge with an existing private business. It acts like a vehicle that allows private companies to go public more quickly and with less complexity. For investors, it offers an opportunity to invest early in a potential acquisition, though it also carries risks if the intended deal doesn’t materialize.

Registration Statement on Form S-4 regulatory

"including a Registration Statement on Form S-4 (File No. 333-297214), which includes the Proxy Statement"

A registration statement on Form S-4 is a formal filing with the U.S. Securities and Exchange Commission used when a company issues shares or other securities as part of a merger, acquisition, exchange offer or similar corporate deal. It bundles the transaction terms, financial statements, risk factors and shareholder vote materials so investors can assess the deal; think of it as a detailed prospectus or buyer’s packet that explains what you would own and how the deal could change your stake.

Proxy Statement regulatory

"The definitive Proxy Statement and other relevant documents have been mailed to shareholders of BCAR"

A proxy statement is a document companies send to shareholders ahead of a meeting that lays out the items up for a vote—like who will sit on the board, executive pay, and major corporate decisions—and provides background so shareholders can decide how to cast their votes or appoint someone to vote for them. Think of it as an agenda plus a ballot and briefing notes, important because the outcomes can change control, strategy, and value.

GPU-as-a-Service technical

"Exascale’s core business includes GPU-as-a-Service, through which it provides reserved and on-demand access"

GPU-as-a-Service is a pay-as-you-go model that lets businesses rent powerful graphics processing units (GPUs) over the internet instead of buying the hardware outright. It matters to investors because it lowers upfront costs and speeds time-to-market for companies using AI, data analysis, or 3D rendering—similar to renting a high-performance car for a specific trip rather than owning one—and can make firms more flexible, scalable, and capital-efficient.

forward-looking statements regulatory

"This press release contains forward-looking statements within the meaning of the “safe harbor” provisions"

Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Understanding 8-K Material Events →

Available on EDGAR 07/08/2026 - 06:47 AM Accepted by SEC EDGAR 07/08/2026 - 06:46 AM

FAQ

What did BCAR (BCAR) announce regarding its merger with Exascale Labs?

BCAR announced that shareholders will vote on the proposed business combination with Exascale Labs at an Extraordinary General Meeting on July 29, 2026, formally moving the SPAC–target transaction into the shareholder approval phase.

When is the BCAR (BCAR) Extraordinary General Meeting to approve the Exascale business combination?

The Extraordinary General Meeting of BCAR shareholders is scheduled for July 29, 2026 at 10:00 a.m. Eastern Time, where investors will vote on approving the Exascale Labs business combination and related proposals.

Who is eligible to vote at the BCAR (BCAR) shareholder meeting on the Exascale merger?

Shareholders of BCAR of record as of Monday, July 6, 2026 are eligible to attend and vote at the Extraordinary General Meeting on the Exascale Labs business combination and related matters outlined in the proxy statement.

How can BCAR (BCAR) shareholders attend and vote at the Extraordinary General Meeting?

BCAR shareholders can attend in person at Loeb & Loeb LLP, 345 Park Avenue, New York, or virtually via www.proxydocs.com/BCAR, using the meeting instructions and proxy voting details provided on their proxy cards.

What is expected to happen if the BCAR–Exascale business combination is approved?

If shareholders approve the business combination and closing conditions are satisfied or waived, the combined company is expected to operate as Exascale Labs Holdings Inc., with its securities trading on Nasdaq under the ticker symbol “XLAB.”

What documents about the BCAR (BCAR) and Exascale business combination are filed with the SEC?

BCAR, Exascale and PubCo have filed a Registration Statement on Form S-4 that includes BCAR’s proxy statement and a prospectus, along with other materials. These documents provide detailed information on the business combination and are available on www.sec.gov.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 7, 2026

D. Boral ARC Acquisition I Corp.

(Exact name of registrant as specified in its charter)

British Virgin Islands

001-42772

00-0000000 N/A

(State or other jurisdiction of

incorporation or organization)

(Commission

File Number)

(I.R.S. Employer

Identification Number)

10 East 53rd Street, Suite 3001

New York, NY 10022

(Address of principal executive offices, including zip code)

+ (332) 266-7344

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions

☒	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant	BCARU	The Nasdaq Stock Market LLC
Class A ordinary shares, par value $0.0001 per share	BCAR	The Nasdaq Stock Market LLC
Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share	BCARW	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b‑2 of the Securities Exchange Act of 1934.

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01. Other Events.

As previously announced, on January 11, 2026, D. Boral ARC Acquisition I Corp. (“BCAR”) entered into an Agreement and Plan of Merger by and among BCAR, D. Boral ARC Merger Corporation, a Delaware corporation and wholly owned subsidiary of BCAR (“PubCo”), D. Boral Arc Merger Sub Inc., a Delaware corporation and a wholly-owned subsidiary of BCAR, and Exascale Labs Inc., a Delaware corporation (“Exascale”) (collectively the “Business Combination”). On July 7, 2026, Exascale issued a press release announcing the scheduling of an Extraordinary General Meeting (the “Meeting”) of BCAR shareholders to approve the Agreement and Plan of Merger and related matters for July 29, 2026 at 10:00 AM Eastern Time. BCAR shareholders of record as of Monday, July 6, 2026, are eligible to attend and vote at the Meeting. The Meeting will be held at the offices of Loeb & Loeb LLP, 345 Park Avenue, New York, NY 10154 and virtually by visiting www.proxydocs.com/BCAR. BCAR shareholders can attend using the meeting instructions set forth on their proxy cards.

Furnished as Exhibit 99.1 hereto and incorporated into this Item 8.01 by reference is the joint press release that Exascale and BCAR issued to announce the scheduling of the Meeting.

The information in this Item 8.01, including Exhibit 99.1, is being furnished and will not be deemed to be filed for purposes of Section 18 of the Securities Act of 1934, as amended (the “Exchange Act”), or otherwise be subject to the liabilities of that section, nor will it be deemed to be incorporated by reference in any filing under the Securities Act or Exchange Act.

Forward Looking Statements

This Current Report on Form 8-K contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as “anticipate,” “believe,” “can,” “continue,” “could,” “expect,” “intend,” “may,” “plan,” “project,” “seek,” “should,” “will,” and similar expressions. These statements include, without limitation, statements regarding the proposed Business Combination, the expected timing and completion of the Business Combination, the operation of PubCo as Exascale Labs Holdings Inc., and the listing of its securities on Nasdaq under the ticker “XLAB.” They also include statements regarding AI infrastructure technologies, the expected demand for AI compute infrastructure, Exascale’s market positioning, and its business strategy, partnerships, and growth.

These statements are based on current expectations and assumptions, and involve risks and uncertainties that could cause actual results or events to differ materially, including, among others, the ability to complete the Business Combination and satisfy closing conditions, changes in customer demand, supply constraints for GPUs and related infrastructure components, competitive pressures, technological risks, operational performance, regulatory changes, and macroeconomic factors.

If any of these risks materialize or the assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that neither BCAR nor Exascale presently know or can anticipate or that BCAR and Exascale currently believe are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect BCAR’s, Exascale’s and PubCo’s expectations, plans or forecasts of future events and views as of the date of this press release. BCAR, Exascale and PubCo anticipate that subsequent events and developments will cause BCAR’s, Exascale’s and PubCo’s assessments to change. However, while BCAR, Exascale and PubCo may elect to update these forward-looking statements at some point in the future, BCAR, Exascale and PubCo specifically disclaim any obligation to do so. Readers are referred to the most recent reports filed with the United States Securities & Exchange Commission (“SEC”) by BCAR. Readers are cautioned not to place undue reliance upon any forward-looking statements.

Additional Information

BCAR, Exascale and Pubco have filed relevant materials with the SEC, including a Registration Statement on Form S-4 (File No. 333-297214), which includes the Proxy Statement of BCAR and a prospectus in connection with Business Combination, referred to as a proxy statement/prospectus. The definitive Proxy Statement and other relevant documents have been mailed to shareholders of BCAR as of a record date established for voting on the proposed Business Combination. SHAREHOLDERS OF BCAR AND OTHER INTERESTED PARTIES ARE URGED TO READ THE REGISTRATION STATEMENT, THE DEFINITIVE PROXY STATEMENT AND ALL OTHER RELEVANT DOCUMENTS FILED OR THAT WILL BE FILED WITH THE SEC IN CONNECTION WITH BCAR’S SOLICITATION OF PROXIES FOR THE EXTRAORDINARY GENERAL MEETING OF ITS SHAREHOLDERS TO BE HELD TO APPROVE THE BUSINESS COMBINATION BECAUSE THESE DOCUMENTS CONTAINS OR WILL CONTAIN IMPORTANT INFORMATION ABOUT BCAR, EXASCALE, PUBCO AND THE BUSINESS COMBINATION. Shareholders can obtain copies of the Registration Statement and the proxy statement/prospectus, without charge, on the SEC’s website at www.sec.gov or by directing a request to: D. Boral ARC Acquisition I Corp., 10 East 53rd Street, Suite 3001, New York, NY 10022; or Exascale, 820 Gessner Road, Suite 332 Houston, TX 77024.

Participants in the Solicitation

Exascale, BCAR and PubCo and their respective directors and executive officers may be deemed under SEC rules to be participants in the solicitation of proxies from BCAR’s shareholders in connection with the Business Combination. A list of the names of such directors and executive officers, and information regarding their interests in the Business Combination and their ownership of BCAR’s and/or PubCo’s securities are contained in the Registration Statement and the Proxy Statement. Information about BCAR’s directors and executive officers is also available in BCAR’s filings with the SEC. You may obtain free copies of these documents from the sources described above.

No Offer or Solicitation

This Current Report on Form 8-K is for informational purposes only and shall not constitute an offer to sell or the solicitation of an offer to buy any securities or the solicitation of any vote in any jurisdiction pursuant to the Business Combination or otherwise, nor shall there be any sale, issuance or transfer of securities in any jurisdiction where such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of that jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.

Item 9.01. Financial Statements and Exhibits.

(d)

Exhibits.

Exhibit No.		Description
99.1*		Press Release, dated July 7, 2026
104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

*	Furnished but not filed.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: July 7, 2026

D. BORAL ARC ACQUISITION I CORP.

By:	/s/ John Darwin
Name:	John Darwin
Title:	Chief Financial Officer

Exhibit 99.1

Exascale Labs and D. Boral ARC Acquisition I Corp. Schedule Extraordinary General Meeting of Shareholders to Approve Business Combination

Extraordinary General Meeting of BCAR Shareholders to Approve Business Combination Scheduled for Wednesday, July 29, 2026

July 07, 2026 16:33 ET | Source: Exascale Labs Inc.; D. Boral ARC Acquisition I Corp.

SAN FRANCISCO, July 07, 2026 (GLOBE NEWSWIRE) — Exascale Labs Inc. (“Exascale” or the “Company”), a provider of next-generation AI compute infrastructure, and D. Boral ARC Acquisition I Corp. (Nasdaq: BCAR) (“BCAR”), a special purpose acquisition company, today announced that the Extraordinary General Meeting of Shareholders of BCAR (the “Meeting”) to approve the previously announced proposed business combination between Exascale and BCAR (the “Business Combination”), pursuant to the Business Combination Agreement between BCAR, Exascale and D. Boral ARC Merger Corporation (“Pubco”), among other parties, entered into as of January 11, 2026 (the “Business Combination Agreement”), has been scheduled for Wednesday, July 29, 2026 at 10:00 Eastern Time.

At the Meeting, BCAR shareholders will be asked to consider and vote upon proposals to approve the Business Combination and related matters. BCAR shareholders of record as of Monday, July 6, 2026, are eligible to attend and vote at the Meeting. The Meeting will be held at the offices of Loeb & Loeb LLP, 345 Park Avenue, New York, NY 10154 and virtually by visiting www.proxydocs.com/BCAR. BCAR shareholders can attend using the meeting instructions set forth on their proxy cards.

The Business Combination is expected to close shortly following the shareholder meeting, subject to BCAR shareholder approval and the satisfaction or waiver of certain closing conditions. Upon closing, the combined company is expected to operate as Exascale Labs Holdings Inc. and its shares are expected to trade on Nasdaq under the ticker symbol “XLAB.”

A definitive proxy statement containing the proposals to be presented at the Meeting has been filed with the SEC (the “Proxy Statement”); copies of the Proxy Statement have been mailed to BCAR shareholders of record as of the record date. Information about how to attend the Meeting and vote is set forth in the Proxy Statement.

Every shareholder’s vote is important, regardless of the number of shares held. Accordingly, BCAR requests that each shareholder complete, sign, date and return a proxy card (online or by mail) as soon as possible to ensure that the shareholder’s shares will be represented at the Meeting.

If any individual BCAR shareholder does not receive the Proxy Statement, such shareholder should (i) confirm his or her Proxy Statement’s status with his or her broker or (ii) contact Advantage Proxy, Inc., BCAR’s proxy solicitor, by email at karen@advantageproxy.com. Individuals may also call Advantage Proxy toll free at 877-870-8565; banks and brokers can call 206-870-8565.

About D. Boral ARC Acquisition I Corp.

BCAR is a special purpose acquisition company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.

About Exascale Labs

Exascale Labs is a next-generation AI infrastructure provider operating an asset-light, software-defined GPU compute platform and related AI infrastructure solutions. Exascale’s core business includes GPU-as-a-Service, through which it provides reserved and on-demand access to high-performance GPU compute capacity sourced from third-party data centers globally, as well as GPU cluster management and optimization services for AI data center operators.

In addition, Exascale has developed certain modular data center, high-density cooling, HVDC power and energy storage solutions designed to address deployment bottlenecks in AI infrastructure. Exascale’s platform is purpose-built for large-scale AI workloads, including LLM training, fine-tuning, and high-concurrency inference. For more information, please visit: https://www.exascalelabs.ai

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as “anticipate,” “believe,” “can,” “continue,” “could,” “expect,” “intend,” “may,” “plan,” “project,” “seek,” “should,” “will,” and similar expressions. These statements include, without limitation, statements regarding the proposed Business Combination, the expected timing and completion of the Business Combination, the operation of PubCo as Exascale Labs Holdings Inc., and the listing of its securities on Nasdaq under the ticker “XLAB.” They also include statements regarding AI infrastructure technologies, the expected demand for AI compute infrastructure, Exascale’s market positioning, and its business strategy, partnerships, and growth.

If any of these risks materialize or the assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that neither BCAR nor Exascale presently know or can anticipate or that BCAR and Exascale currently believe are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect BCAR’s, Exascale’s and Pubco’s expectations, plans or forecasts of future events and views as of the date of this press release. BCAR, Exascale and Pubco anticipate that subsequent events and developments will cause BCAR’s, Exascale’s and Pubco’s assessments to change. However, while BCAR, Exascale and Pubco may elect to update these forward-looking statements at some point in the future, BCAR, Exascale and Pubco specifically disclaim any obligation to do so. Readers are referred to the most recent reports filed with the SEC by BCAR. Readers are cautioned not to place undue reliance upon any forward-looking statements.

Additional Information

Participants in the Solicitation

Exascale, BCAR and Pubco and their respective directors and executive officers may be deemed under SEC rules to be participants in the solicitation of proxies from BCAR’s shareholders in connection with the Business Combination. A list of the names of such directors and executive officers, and information regarding their interests in the Business Combination and their ownership of BCAR’s and/or PubCo’s securities are contained in the Registration Statement and the Proxy Statement. Information about BCAR’s directors and executive officers is also available in BCAR’s filings with the SEC. You may obtain free copies of these documents from the sources described above.

No Offer or Solicitation

This press release is for informational purposes only and shall not constitute an offer to sell or the solicitation of an offer to buy any securities or the solicitation of any vote in any jurisdiction pursuant to the Business Combination or otherwise, nor shall there be any sale, issuance or transfer of securities in any jurisdiction where such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of that jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.

Investor Contact

Nick Hresko-Staab
KCSA Strategic Communications
Exascale@KCSA.com

Media Contact

Hannah Erger
KCSA Strategic Communications
Exascale@KCSA.com

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

5 documents

Press Releases

EX-99.1 EXHIBIT 99.1 17.0 KB

Exascale Labs–BCAR (NASDAQ: BCAR) merger vote set for Jul 29

Rhea-AI Filing Summary

Positive

Negative